Cargando…
Dual 5-HT(3) and 5-HT(6) Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats
Schizophrenia is a severe mental disorder featuring psychotic, depressive, and cognitive alterations. Current antipsychotic drugs preferentially target dopamine D(2)-R and/or serotonergic 5-HT(2A/1A)-R. They partly alleviate psychotic symptoms but fail to treat negative symptoms and cognitive defici...
Autores principales: | Castañé, Anna, Cano, Montserrat, Ruiz-Avila, Luis, Miquel-Rio, Lluís, Celada, Pau, Artigas, Francesc, Riga, Maurizio S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154270/ https://www.ncbi.nlm.nih.gov/pubmed/35022720 http://dx.doi.org/10.1093/ijnp/pyac003 |
Ejemplares similares
-
Structure-Based
Design and Optimization of FPPQ, a
Dual-Acting 5-HT(3) and 5-HT(6) Receptor
Antagonist with Antipsychotic and Procognitive Properties
por: Zajdel, Paweł, et al.
Publicado: (2021) -
5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991) -
5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT
por: Sia, Tiong C., et al.
Publicado: (2013) -
Constitutively Active 5-HT Receptors: An Explanation of How 5-HT Antagonists Inhibit Gut Motility in Species Where 5-HT is Not an Enteric Neurotransmitter?
por: Spencer, Nick J.
Publicado: (2015) -
Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)